[PDF] Top 20 Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin

Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin

... hepatitisa C (HCV) najčešći je uzrok razvoja hronič- ne infekcije, ciroze jetre i hepatocelularnog karcinoma u ...hronični hepatitis C. Klinički ma- nifestna forma akutnog hepatitisa C je ... See full document

4

Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil

... The treatment of chronic hepatitis C (CHC) with peginterferon alpha-2b/ribavirin (PegIFN + Rib) produced larger sustained viral response (SVR) compared to the ... See full document

9

Psychosis during peginterferon-alpha2a and ribavirin therapy: case report

... probability of emergent psychiatric comorbidity during IFN-alpha treatment, including previous history of any psychiatric illness, a history of substance abuse, a family history ... See full document

2

Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy

... weeks of conventional IFN and ribavirin combination therapy achieved 26% of SVR when retreated with peginterferon alfa-2a (40KD) plus ribavirin for 48 ...(SVR ... See full document

6

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

... introduction of ribavirin in combination with IFN-a or pegylated IFN-a for HBV/HCV dually infected patients has been shown to be as effective for patients with HCV monoinfection in terms ... See full document

9

Weight-based combination therapy with peginterferon alpha-2b and ribavirin for Naïve, relapser and non-responder patients with chronic hepatitis C

... therapy with peginterferon α-2b plus ribavirin in naïve Brazilian patients with chronic hepatitis C were similar to those obtained in the pivotal multicentric phase III ... See full document

6

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy

... consisted of combined administration of standard interferon (3MU three times weekly) or peginterferon (α2b ...once-weekly) plus ribavirin (body weight < 75 kg: ...to ... See full document

6

Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin

... end of treatment] are observed in approximately half of the treated patients and many factors, such as age, genotype, viral load and body weight, are related to treatment outcome (Manns et ... See full document

6

Response to treatment with interferon-alpha and ribavirin in patients with chronic Hepatitis C virus genotypes 2 and 3 depends on the degree of hepatic fibrosis

... Combined treatment with interferon alfa (INF-α) plus ribavirin (RBV) has revolutionized the therapy of chronic hepatitis caused by the hepatitis C virus (HCV) ... See full document

4

Arq. NeuroPsiquiatr. vol.67 número3A

... prior with chronic hepatitis C, genotype 3, and probably infected via a blood transfusion performed 16 years earlier, presented to the Fundação de Medicina Tropical do Amazonas complaining of ... See full document

2

IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT- RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS

... records of all the patients with cirrhosis due to chronic hepatitis C who underwent treatment with dual therapy (PEG-IFN and ...PEG-IFN alpha-2a 180 mcg or PEG-IFN ... See full document

6

Universidade Federal de Uberlândia Faculdade de Medicina Sandra Regina Xavier Santos

... al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus ...BUFFET, C. Evolution and predictive factors of thyroid disorder due to interferon ... See full document

70

Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.

... analysis of the selective forces acting on two hepatitis C virus genome regions previously postulated to be involved in the viral response to combined antiviral ...cohort of 22 non-responder ... See full document

14

Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naive Patients in Chile.

... infections, hepatitis C is considered a curable disease if a state known as sustained virological response (SVR) is attained with adequate pharmacological ...available treatment was ... See full document

16

Braz. J. Pharm. Sci. vol.50 número2

... HCV treatment (2007) recommended that the irst choice treatment for patients with chronic hepatitis C (CHC) and genotype 2 or 3 is interferon alpha (IFN) plus ... See full document

8

Fallbericht: Peginterferon plus Ribavirin durch 110 Wochen bei einem Patienten mit chronischer Hepatitis C Genotyp 1 und sehr langsamem virologischem Ansprechen

... Datz C, Löschenberger K, Formann E, Staufer K, Steindl-Munda P; Austrian Hepatitis Study ...Group. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 ... See full document

5

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.

... years), treatment-naive Caucasians with CHC, HCV GT3 mono-infection, with baseline serum HCV RNA levels 50 ...Switzerland) plus RBV (COPEGUS1, Roche) at a planned dose of 800, 1000, or ... See full document

20

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus

... patient with HCV- induced cryglobulinemic MPGN with ribavirin alone, and observed an improvement of hepatic and renal disease at the end of the ...end of the treatment, ... See full document

5

Aktuelles Management der HIV/HCV-Koinfektion

... recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected ...Management of hepatic complications in ... See full document

11

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

... chronic hepatitis C (CHC), the disease caused by genotype 3 virus (GEN3) is still considered a treatment challenge in certain patient ...aim of this retrospective study was to evaluate the ... See full document

8